Abiopharma

🔍 Hettinger Shawna M. (Director)

Company: HAWTHORN BANCSHARES, INC. (HWBK)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 645 shares of Common Stock at $38.75 per share (Direct)
  Date: 2026-08-26 | Code: P | equity_swap_involved: 0 | shares_owned_after: 4,769.16 | transaction_form_type: 4 | Footnotes: F1
• Acquired 654 shares of Common Stock at $38.2 per share (Direct)
  Date: 2026-08-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 5,423.61 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | shares_owned_after: 500.00 | Footnotes: F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $38.62 to $38.75 inclusive. The reporting person undertakes to provide to Hawthorn Bancshares, Inc. any security holding of Hawthorn Bancshares, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
• F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $38.20 to $38.28 inclusive. The reporting person undertakes to provide to Hawthorn Bancshares, Inc. any security holding of Hawthorn Bancshares, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
• F3: Represents unvested restricted stock units ("RSUs") granted under the Hawthorn Bancshares, Inc. Equity Incentive Plan that can be settled only in shares of Common Stock. The RSUs will fully vest on June 2, 2027.